Last reviewed · How we verify
Echinococcus Granulosus Infection of the Peritoneum
Approved treatments
- Albenza · Impax Labs Inc
Albenza works by binding to tubulin in the parasite's microtubules, disrupting their function and ultimately leading to the parasite's death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Echinococcus Granulosus Infection of the Peritoneum patent landscape — cliff calendar, originator estates, attackable patents
- Echinococcus Granulosus Infection of the Peritoneum treatment landscape brief
- Echinococcus Granulosus Infection of the Peritoneum treatment updates RSS
Frequently asked questions about Echinococcus Granulosus Infection of the Peritoneum
What drugs treat Echinococcus Granulosus Infection of the Peritoneum?
Tracked treatments include Albenza.
What is the treatment for Echinococcus Granulosus Infection of the Peritoneum?
Standard treatment for Echinococcus Granulosus Infection of the Peritoneum includes Albenza. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Echinococcus Granulosus Infection of the Peritoneum patent cliff · Echinococcus Granulosus Infection of the Peritoneum CI report
- Treatment: Albenza · Impax Labs Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing